We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Anticancer Therapies – Products

The Predictive Oncology and Cancer Research Horizons logos.
Product News

Predictive Oncology and Cancer Research Horizons Partnered To Develop of Cancer Drugs

Predictive Oncology Inc. together with Cancer Research Horizons, announce that they have partnered to drive the development of oncology drugs utilizing Predictive Oncology’s PEDAL™ platform.
The SonALAsense logo
Product News

SonALAsense Announces Completion of First Cohort in Phase 2 Study of Sonodynamic Therapy for Recurrent Glioblastoma

SonALAsense has announced that the first cohort in Sonodynamic Therapy (SDT)-202 was fully enrolled.
The Terumo Blood and Cell Technologies logo
Product News

Terumo Blood and Cell Technologies’ Platelet Pooling Set Cleared by FDA

Terumo Blood and Cell Technologies has announced US Food and Drug Administration clearance and official launch of its IMUGARD(R)WB Platelet Pooling Set, which supports extended shelf life of whole blood-derived platelets from five days to seven days.
The Akamis Bio logo
Product News

Akamis Bio, Parker Institute for Cancer Immunotherapy and Cancer Research Institute Expand Partnership

Akamis Bio has announced an expansion of its ongoing partnership with the Parker Institute for Cancer Immunotherapy to include a clinical collaboration with the Cancer Research Institute that will focus on advancing novel treatments for pancreatic cancer.
Two hands holding jigsaw pieces representing a partnership.
Product News

Personalis and Moderna Sign New Agreement To Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials

The platform will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.
Dr Alastair Smith, Chief Executive Officer of Avacta Group.
Product News

Avacta Announces Successful Completion of Fourth Dose Escalation in Phase 1 Clinical Study

Avacta Group plc announces that AVA6000 continues to show a very favorable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation phase 1 clinical trial.
Potentiating CD16-Activated ADCC in CAR-NK Cell Therapy content piece image

Potentiating CD16-Activated ADCC in CAR-NK Cell Therapy

Sino Biological has developed a panel of quality proteins and antibodies for CD16 and accompanying molecules to support CAR-NK cell therapy research.
Rack of tubes containing blood in a laboratory.
Product News

Personalis and UCSF To Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer

Personalis has announced a collaboration with UC San Francisco that will deploy a personalized liquid biopsy-based research use only assay for a study of patients with colorectal cancer.
Actym Therapeutics logo
Product News

Actym Therapeutics Reports Preclinical Data Demonstrating ACTM-838’s Ability To Generate Anti-Tumor Immunity

Actym Therapeutics has announced that an abstract highlighting detailed preclinical data of its lead candidate, ACTM-838, was accepted for presentation at the Society for Immunotherapy of Cancer 37th Annual Meeting.
The OncoHost logo
Product News

OncoHost To Present Proteomics-Based Biomarker Model for Clinical Benefit to Immunotherapy in NSCLC Patients at SITC 2022

OncoHost has developed a novel predictive model for clinical benefit of immune checkpoint inhibitor in non-small cell lung cancer patients.